top of page

Teladoc Health: This 'Expanding' Company Is A Long-Term Buy


- Teladoc Health recently announced that it entered into an agreement to acquire a European telemedicine provider and that it had plans to expand into Canada.

- The stock is not cheap, but I do not believe that Teladoc's growth prospects are fully baked into the price.

- I am long Teladoc Health, and I plan to stay long the stock.

Teladoc Health's ($TDOC) stock has underperformed the broader market so far in 2019, but shares have significantly outperformed the S&P 500 ($SPY) over the last year.

There are plenty of reasons to like Teladoc in today's environment - read this latest article for my thoughts on the company's bull case - but I believe that the recent announcements related to management's expansion plans should get investors even more excited about what the future may hold for this growing, disruptive company.

Read more here.

bottom of page